Global Health Limited — Investor Meet, 13-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Medanta's Q2 FY26 earnings call highlighted strong performance and strategic expansion. Consolidated total income rose 15% YoY to **1,118.9 Cr**, with Profit After Tax up 21% to **158.4 Cr**. EBITDA, excluding the new Noida hospital, grew 14% to **280.4 Cr** (25.2% margin). The company maintains a strong balance sheet with a net cash surplus of **708.2 Cr**.

Medanta Noida commenced operations in September with 226 beds, generating **3.9 Cr** revenue and a **19.7 Cr** EBITDA loss in its first month, aligning with expectations for a new facility ramp-up. Lucknow and Patna hospitals continue to deliver strong double-digit growth. International patient revenue significantly increased by 49%.

Major expansion plans are progressing: land acquired for a 400+ bed hospital in Guwahati, with construction starting soon. The Mumbai project expanded to 750 beds at a revised cost of **1,530 Cr**. Management expresses confidence in sustained growth, ongoing strategic investments in new units, and attracting top clinical talent amidst industry competition.